[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Toros University\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":217},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,47,68,107,133,162,191],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100054083","scapulothoracic-stabilization-and-postural-training-in-upper-extremity-lymphedema-100054083",false,"NCT07697495","Scapulothoracic Stabilization and Postural Training in Upper Extremity Lymphedema","Effects of Scapulothoracic Stabilization and Postural Training Added to Standard Lymphedema Care on Muscle Strength, Posture and Functional Outcomes in Secondary Upper Extremity Lymphedema: A Single-Center Randomized Controlled Trial","Inclusion Criteria:\n\n* Female patients aged 18 to 65 years.\n* Diagnosed with secondary upper extremity lymphedema following breast cancer surgery (mastectomy).\n* Willing to participate in the study.\n* Able to provide written informed consent.\n\nExclusion Criteria:\n\n* Active infection (e.g., cellulitis or lymphangitis).\n* Advanced shoulder or cervical pathology.\n* Neurological disorders affecting upper extremity function.\n* Metastatic disease.\n* Receiving active chemotherapy.\n* Participation in another intensive lymphedema rehabilitation program within the previous 3 months.","FEMALE","18 Years","65 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","This single-center randomized controlled trial aims to investigate the effects of adding scapulothoracic stabilization and postural training to standard lymphedema care in women with secondary upper extremity lymphedema following breast cancer surgery. Participants will be randomly assigned to receive either standard lymphedema care alone or standard care combined with scapulothoracic stabilization and postural training. Outcomes including scapular muscle strength, posture, upper extremity function, limb volume, and neck awareness will be assessed at baseline, immediately after treatment, and at a 2-month follow-up. The findings are expected to provide evidence regarding the effectiveness of incorporating targeted stabilization and postural exercises into conventional lymphedema rehabilitation.",[27],"Secondary Lymphedema",[29,30,31,32,33],"Upper Extremity Lymphedema","Scapulothoracic Stabilization","Postural Training","Muscle Strength","Posture","RECRUITING","2026-07-10",{"date":37,"type":38},"2026-07-13","ACTUAL",{"date":40,"type":38},"2026-03-01",{"date":42,"type":21},"2027-03",{"name":44,"class":45},"Toros University","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":64,"startDateStruct":65,"completionDateStruct":66,"leadSponsor":67,"locationsCount":46},"100053260","respiratory-and-relaxation-training-in-lower-extremity-lymphedema-100053260","NCT07697482","Respiratory and Relaxation Training in Lower Extremity Lymphedema","Effect of Respiratory and Relaxation Training Added to Complex Decongestive Therapy on Functional Capacity and Muscle Oxygenation in Patients With Lower Extremity Lymphedema: A Single-Center Randomized Controlled Trial","Inclusion Criteria:\n\n* Female patients aged 18 years or older.\n* Clinically diagnosed with secondary lower extremity lymphedema.\n* Presence of lower extremity lymphedema for at least 3 months.\n* Able to stand and walk independently to complete the Six-Minute Walk Test.\n* Willing and able to provide written informed consent.\n\nExclusion Criteria:\n\n* Acute cellulitis or other active infection within the previous 2-4 weeks.\n* Current or recent deep vein thrombosis (DVT) or uncontrolled peripheral vascular disease.\n* Severe cardiovascular, pulmonary, orthopedic, or neurological conditions that could interfere with participation or outcome assessments.\n* Pregnancy.\n* Skin lesions or irritation preventing placement of the near-infrared spectroscopy (MOXY) sensor.\n* Inability to comply with the study protocol or follow-up assessments.",{"count":20,"type":21},[24],"This randomized controlled trial aims to investigate the effectiveness of respiratory and relaxation training added to standard complex decongestive therapy (CDT) on muscle oxygenation, functional capacity, and limb volume in patients with lower extremity lymphedema. Participants will be randomly assigned to receive either standard CDT alone or CDT combined with respiratory and relaxation exercises. Outcomes will be assessed before treatment, immediately after treatment, and two months after completion.",[58],"Lower Extremity Lymphedema",[58,60,61,62,63],"Complex Decongestive Therapy","Respiratory Training","Relaxation Training","Muscle Oxygenation",{"date":37,"type":38},{"date":40,"type":38},{"date":42,"type":21},{"name":44,"class":45},{"id":69,"slug":70,"hasResults":11,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":4,"studyType":81,"phases":4,"briefSummary":82,"conditions":83,"keywords":89,"overallStatus":98,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":46},"100643167","evaluation-of-metabolic-parameters-intestinal-permeability-and-gastrointestinal-symptoms-after-bariatric-surgery-in-body-weight-management-100643167","NCT07643376","Evaluation of Metabolic Parameters, Intestinal Permeability and Gastrointestinal Symptoms After Bariatric Surgery in Body Weight Management","Evaluation of Postoperative Metabolic Parameters, Intestinal Permeability and Gastrointestinal Symptoms in Body Weight Management After Laparoscopic Sleeve Gastrectomy","METABAR","Inclusion Criteria:\n\n* Underwent Laparoscopic Sleeve Gastrectomy (LSG) within the last 1 month\n* Aged between 19-50 years\n* BMI ≥40 kg\u002Fm² or BMI ≥35 kg\u002Fm² with obesity-related comorbidities\n* Signed informed consent form\n* Non-smoker and non-alcohol dependent\n\nExclusion Criteria:\n\n* Did not undergo or is not planned to undergo LSG\n* Outside the age range of 19-50 years\n* Did not sign the informed consent form\n* BMI \\\u003C40 kg\u002Fm² or BMI \\\u003C35 kg\u002Fm² without obesity-related comorbidities\n* Smoker or alcohol dependent\n* Has an inflammatory disease\n* Currently using probiotics, antibiotics, or fiber supplements\n* Has a psychiatric disorder","ALL","19 Years","50 Years",{"count":80,"type":21},40,"OBSERVATIONAL","This study aims to evaluate the changes in metabolic parameters, intestinal permeability, and gastrointestinal symptoms in individuals who have undergone bariatric surgery (Laparoscopic Sleeve Gastrectomy - LSG) for obesity treatment.\n\nObesity is a chronic disease associated with serious health complications including type 2 diabetes, hypertension, cardiovascular disease, and metabolic disorders. Bariatric surgery is currently the most effective treatment method for morbid obesity. However, monitoring patients after surgery in terms of metabolic health, gut permeability, and gastrointestinal symptoms is crucial for long-term success.\n\nIn this study, 40 volunteers (aged 19-50) who have undergone LSG surgery within the last month will be followed for 6 months. At the beginning of the study and 6 months later, the following will be assessed:\n\n* Metabolic parameters: fasting blood glucose, total cholesterol, triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), very low-density lipoprotein (VLDL) cholesterol, and insulin levels\n* Intestinal permeability markers: zonulin, secretory immunoglobulin A (IgA), and lipopolysaccharide (LPS) levels\n* Gastrointestinal symptoms: assessed using the Gastrointestinal Symptom Rating Scale (GSRS)\n* Anthropometric measurements: body weight, height, waist and hip circumference, BMI\n* Nutritional intake: 3-day dietary records\n\nThe study will be conducted at Bursa Yıldırım Doruk Hospital, General Surgery Clinic. Results will contribute to understanding the relationship between bariatric surgery and gut health, potentially helping to prevent postoperative complications.",[84,85,86,87,88],"Obesity, Morbid","Bariatric Surgery","Intestinal Permeability","Gastrointestinal Symptoms","Metabolic Syndrome",[90,91,92,93,94,95,96,97],"Laparoscopic Sleeve Gastrectomy","Zonulin","Secretory IgA","Lipopolysaccharide","GSRS","Body Weight Management","Gut microbiota","Postoperative Metabolic Parameters","NOT_YET_RECRUITING","2026-06-08",{"date":101,"type":38},"2026-06-11",{"date":103,"type":21},"2026-07-01",{"date":105,"type":21},"2027-02-01",{"name":44,"class":45},{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":113,"eligibilityCriteria":114,"healthyVolunteers":115,"sex":76,"minAge":18,"maxAge":4,"enrollmentInfo":116,"targetDuration":4,"studyType":81,"phases":4,"briefSummary":118,"conditions":119,"keywords":122,"overallStatus":98,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":46},"100604278","turkish-validation-of-the-aloc-screening-scale-in-older-adults-100604278","NCT07147439","Turkish Validation of the ALOC Screening Scale in Older Adults","Turkish Validity and Reliability of the Appetite Loss in Older Adults With and Without Cognitive Impairment (ALOC) Screening Scale","ALOC","Inclusion Criteria:\n\n* Elderly over 65 years, with or without cognitive impairment\n\nExclusion Criteria:\n\n\\-",true,{"count":117,"type":21},300,"As the elderly population increases, health problems related to aging are also increasing. Loss of appetite negatively affects public health by causing malnutrition and related health problems in elderly individuals. Loss of appetite is a common problem in older adults, both in individuals with and without cognitive impairment. This can lead to serious health problems such as malnutrition, weight loss, muscle loss, weakening of the immune system and decreased quality of life. Cognitive disorders such as Alzheimer's and dementia can trigger loss of appetite, or loss of appetite can be a symptom of these disorders. Factors such as metabolic changes during the aging process, decreased sense of taste and smell, loneliness and depression contribute to loss of appetite. However, there is no valid and reliable scale in Turkey for the early diagnosis and assessment of loss of appetite. A scale being valid and reliable means that it can measure the concept it is intended to measure accurately and consistently. The aim of this study was to determine the validity and reliability of the Turkish version of the Loss of Appetite Scale in older adults with and without cognitive impairment .",[120,121],"Elderly (People Aged 65 or More)","With or Without Cognitive Impairment",[123,113,124,125],"Elderly","SNAQ","TURKISH VALIDITY AND RELIABILITY",{"date":127,"type":38},"2026-06-10",{"date":129,"type":21},"2026-09-01",{"date":131,"type":21},"2026-12-01",{"name":44,"class":45},{"id":134,"slug":135,"hasResults":11,"nctId":136,"briefTitle":137,"officialTitle":138,"acronym":4,"eligibilityCriteria":139,"healthyVolunteers":11,"sex":76,"minAge":17,"maxAge":4,"enrollmentInfo":140,"targetDuration":4,"studyType":22,"phases":142,"briefSummary":143,"conditions":144,"keywords":149,"overallStatus":98,"whyStopped":4,"lastUpdateSubmitDate":155,"lastUpdatePostDateStruct":156,"startDateStruct":158,"completionDateStruct":159,"leadSponsor":161,"locationsCount":4},"100634547","cancer-awareness-among-syrian-migrants-100634547","NCT07541105","Cancer Awareness Among Syrian Migrants","A Theory-Driven Educational Intervention to Enhance Cancer Screening Uptake Among Syrian Migrants in Turkey: A Study Protocol","Inclusion Criteria:\n\n* over 18 years of age\n* hold Syrian citizenship\n* be registered with the Migrant Health Center in Mersin province\n* have proficiency in Turkish or Arabic\n* voluntarily agree to participate\n\nExclusion Criteria:\n\n* if they hold Turkish citizenship\n* have a diagnosed psychiatric disorder\n* have been diagnosed with cancer\n* wish to withdraw from the study",{"count":141,"type":21},30,[24],"This study aims to develop and evaluate a theory-based educational intervention to improve cancer screening participation among Syrian migrants in Turkey. The study will also develop a Cancer Protection Motivation Scale (CPMS) to measure individuals' motivation toward cancer screening. Using a mixed-methods design, the study will explore barriers, beliefs, and behaviors related to breast, cervical, and colorectal cancer screening. The effectiveness of the intervention will be assessed using a pretest-posttest design. The findings are expected to support culturally appropriate strategies to improve cancer screening uptake among migrant populations.",[145,146,147,148],"Breast Cancer Screening","Cervical Cancer Screening","Colorectal Cancer Screening","Cancer Prevention Behavior",[150,151,152,153,154],"Breast cancer","Colon cancer","Cervical cancer","Protection motivation","Reduced inequalities","2026-04-20",{"date":157,"type":38},"2026-04-24",{"date":155,"type":21},{"date":160,"type":21},"2026-07-15",{"name":44,"class":45},{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":167,"acronym":4,"eligibilityCriteria":168,"healthyVolunteers":11,"sex":76,"minAge":169,"maxAge":170,"enrollmentInfo":171,"targetDuration":4,"studyType":22,"phases":173,"briefSummary":174,"conditions":175,"keywords":177,"overallStatus":98,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":190,"locationsCount":4},"100602712","intravenous-catheter-application-100602712","NCT07127081","Intravenous Catheter Application","The Effect of Stress Ball and Watching Cartoons on Pain and Fear During Intravenous Catheter Application in Children: A Randomised Controlled Study","Inclusion Criteria:\n\n* Those who were admitted to Toros State Hospital, Child service on 01 September 2025- 01.02.2026,\n* Children aged 6 to 12 years,\n* Children scheduled for intravenous catheterisation,\n* Children without mental and developmental retardation,\n* Children who can speak and understand Turkish,\n* Children and parents who signed an informed consent form.\n\nExclusion Criteria:\n\n* Children who cannot speak or communicate in Turkish,\n* Children whose first attempt to insert an intravenous catheter failed,\n* Children and parents who did not sign the informed consent form.","6 Years","12 Years",{"count":172,"type":21},90,[24],"The study was a randomised controlled trial showing the effect of watching cartoons and squeezing a stress ball on pain and fear in children admitted for intravenous catheter insertion. Hypotheses of the Study Hypothesis 1: Children who watch cartoons during intravenous catheter insertion have lower pain and fear scores than the control group.\n\nHypothesis 2: The pain and fear of children who squeeze a stress ball during intravenous catheter insertion are lower than the control group Hypothesis 3: There is a difference between the pain and fear scores of children who watch cartoons and squeeze a stress ball.",[176],"6-12 Years Old",[178,179,180,181,182],"Children","intravenous catheter","stress ball","cartoons","nursing","2025-08-20",{"date":185,"type":38},"2025-08-27",{"date":187,"type":21},"2025-09-01",{"date":189,"type":21},"2026-05-01",{"name":44,"class":45},{"id":192,"slug":193,"hasResults":11,"nctId":194,"briefTitle":195,"officialTitle":196,"acronym":4,"eligibilityCriteria":197,"healthyVolunteers":11,"sex":76,"minAge":17,"maxAge":18,"enrollmentInfo":198,"targetDuration":4,"studyType":22,"phases":199,"briefSummary":200,"conditions":201,"keywords":203,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":209,"lastUpdatePostDateStruct":210,"startDateStruct":212,"completionDateStruct":214,"leadSponsor":216,"locationsCount":46},"100589075","effect-of-dual-task-training-and-cognitive-rehabilitation-in-individuals-with-multiple-sclerosis-100589075","NCT06949696","Effect of Dual-Task Training and Cognitive Rehabilitation in Individuals With Multiple Sclerosis.","Effects of Dual-Task Training and Cognitive Rehabilitation on Gait, Balance, Fatigue and Cognitive Performance in Individuals With Multiple Sclerosis","Inclusion Criteria:\n\n* Definite MS diagnosis by a neurologist\n* Can walk independently\n* Expanded Disability Status Scale (EDSS) score below 5\n* Has not had an attack in the last 3 months, has been medically stable for 6 months\n* Has not received a regular physiotherapy program in the last 6 months volunteer\n\nExclusion Criteria:\n\n* Scoring 26 or below on the Montreal Cognitive Assessment Scale (MoCA)\n* Having systemic, orthopedic and neurological problems that may affect walking and balance in the assessments\n* Having additional psychiatric disorders",{"count":141,"type":21},[24],"The purpose of this study is to examine the effects of dual-task training and cognitive rehabilitation on gait, balance, fatigue and cognitive performance in individuals with multiple sclerosis.",[202],"Multiple Sclerosis",[204,205,206,207,208],"multiple sclerosis","balance","gait","dual task","fatigue","2025-04-22",{"date":211,"type":38},"2025-04-29",{"date":213,"type":38},"2025-04-20",{"date":215,"type":21},"2026-06-01",{"name":44,"class":45},""]